Does the Healthy Eating Index and Mediterranean Diet Score Identify the Nutritional Adequacy of Dietary Patterns in Chronic Pancreatitis?


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
08 2019
Historique:
received: 23 08 2018
accepted: 14 02 2019
pubmed: 25 2 2019
medline: 26 2 2020
entrez: 25 2 2019
Statut: ppublish

Résumé

Chronic pancreatitis (CP) is a progressive, irreversible disease characterized by maldigestion and frequently accompanied by epigastric pain, exocrine insufficiency, and/or endocrine insufficiency. There is limited information about the dietary patterns in CP from which to guide medical nutrition therapy recommendations. Study design was a cross-sectional, case-control study comparing subjects with CP (n = 52) to healthy controls (n = 48). Vioscreen™ food frequency questionnaire was used to assess the dietary pattern and nutrient intake in both groups. Dietary quality scores (the Healthy Eating Index, Mediterranean Diet score), and daily energy, macronutrient, and micronutrient intake levels were compared between groups. Two sample t tests and Wilcoxon rank sum tests were used to evaluate differences in continuous variables, and Chi-squared tests were used for categorical variables. CP was associated with a lower body mass index (BMI) (24 vs. 31 mg/kg The overall quality of dietary intake is lower in subjects with CP compared to controls when assessed by two independent nutritional measurement tools. Further research is needed to examine contributing factors, such as food insecurity and coexisting endocrine or exocrine insufficiency, to dietary patterns in patients with CP from which to guide evidence-based recommendations for medical nutritional therapy.

Sections du résumé

BACKGROUND
Chronic pancreatitis (CP) is a progressive, irreversible disease characterized by maldigestion and frequently accompanied by epigastric pain, exocrine insufficiency, and/or endocrine insufficiency. There is limited information about the dietary patterns in CP from which to guide medical nutrition therapy recommendations.
METHODS
Study design was a cross-sectional, case-control study comparing subjects with CP (n = 52) to healthy controls (n = 48). Vioscreen™ food frequency questionnaire was used to assess the dietary pattern and nutrient intake in both groups. Dietary quality scores (the Healthy Eating Index, Mediterranean Diet score), and daily energy, macronutrient, and micronutrient intake levels were compared between groups.
ANALYSIS
Two sample t tests and Wilcoxon rank sum tests were used to evaluate differences in continuous variables, and Chi-squared tests were used for categorical variables.
RESULTS
CP was associated with a lower body mass index (BMI) (24 vs. 31 mg/kg
CONCLUSIONS
The overall quality of dietary intake is lower in subjects with CP compared to controls when assessed by two independent nutritional measurement tools. Further research is needed to examine contributing factors, such as food insecurity and coexisting endocrine or exocrine insufficiency, to dietary patterns in patients with CP from which to guide evidence-based recommendations for medical nutritional therapy.

Identifiants

pubmed: 30798461
doi: 10.1007/s10620-019-05536-3
pii: 10.1007/s10620-019-05536-3
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2318-2326

Références

J Acad Nutr Diet. 2014 Apr;114(4):613-21
pubmed: 24462267
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Nutr Clin Pract. 2014 Jun;29(3):348-54
pubmed: 24727205
Pancreatology. 2013 Jan-Feb;13(1):33-7
pubmed: 23395567
Am J Clin Nutr. 2005 Jul;82(1):163-73
pubmed: 16002815
J Nutr Metab. 2011;2011:398324
pubmed: 22187639
World J Gastroenterol. 2013 Nov 14;19(42):7267-75
pubmed: 24259957
Dig Dis Sci. 2017 Jul;62(7):1745-1750
pubmed: 28281169
JOP. 2012 Sep 10;13(5):519-28
pubmed: 22964959
Eur J Epidemiol. 2013 Apr;28(4):317-28
pubmed: 23579425
Gastroenterology. 2013 Jun;144(6):1282-91.e3
pubmed: 23622138
Comput Methods Programs Biomed. 2006 Jul;83(1):73-7
pubmed: 16806570
World J Gastroenterol. 2009 Apr 14;15(14):1673-6
pubmed: 19360910
Prev Med. 2007 Apr;44(4):335-40
pubmed: 17350085
Am J Gastroenterol. 2004 Nov;99(11):2256-70
pubmed: 15555009
Br J Cancer. 2015 Dec 1;113(11):1607-14
pubmed: 26575601
Clin Nutr. 2014 Aug;33(4):678-83
pubmed: 24064253
Public Health Nutr. 2008 Feb;11(2):183-95
pubmed: 17610761
Nutr Metab Cardiovasc Dis. 2006 Dec;16(8):559-68
pubmed: 17126772
Gastroenterology. 2013 Jun;144(6):1252-61
pubmed: 23622135
Pancreas. 2014 Nov;43(8):1143-62
pubmed: 25333398
Clin Nutr ESPEN. 2015 Apr;10(2):e66-e70
pubmed: 28531461
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
Nutrition. 2014 Jun;30(6):613-8
pubmed: 24800663
Pancreatology. 2015 Nov-Dec;15(6):589-97
pubmed: 26243045
Am J Clin Nutr. 2006 Apr;83(4):941S-944S
pubmed: 16600952
Pediatrics. 2010 Jul;126(1):e26-32
pubmed: 20595453
Nutr Res. 2018 Apr;52:1-13
pubmed: 29764623
Maturitas. 2010 Feb;65(2):122-30
pubmed: 19656644
Nutr Clin Pract. 2014 Jun;29(3):295-311
pubmed: 24743046
J Nutr Biochem. 2007 Mar;18(3):149-60
pubmed: 16963247
Dig Dis Sci. 1996 Mar;41(3):533-9
pubmed: 8617130

Auteurs

Kristen M Roberts (KM)

Ohio State University, 453 West 10th Avenue, Columbus, OH, 43210, USA. kristen.roberts@osumc.edu.

Paige Golian (P)

Ohio State University, 453 West 10th Avenue, Columbus, OH, 43210, USA.

Marcia Nahikian-Nelms (M)

Ohio State University, 453 West 10th Avenue, Columbus, OH, 43210, USA.

Alice Hinton (A)

Ohio State University, 1841 Neil Ave., Columbus, OH, 43210, USA.

Peter Madril (P)

Ohio State University, 453 West 10th Avenue, Columbus, OH, 43210, USA.

Kathleen Basch (K)

Ohio State University, 453 West 10th Avenue, Columbus, OH, 43210, USA.

Darwin Conwell (D)

Ohio State University, 410 West 10th Avenue, Columbus, OH, 43210, USA.

Phil A Hart (PA)

Ohio State University, 410 West 10th Avenue, Columbus, OH, 43210, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH